After buying health company Vectura, tobacco giant Philip Morris will profit from treating the illnesses its products create
By Kristin Carson-Chahhoud, Associate Research Professor, University of South Australia
Bruce Thompson, Professor and Dean of the School of Health Sciences, Swinburne University of Technology
John Upham, Professor of Respiratory Medicine, The University of Queensland
Tobacco giant Philip Morris has acquired British company Vectura, which make puffers and nebulisers that help people with lung disease to breathe.
Read complete article
© The Conversation
- Thursday, September 30, 2021